Lackner Mark - Insider Non-Derivative Transactions at Zentalis Pharmaceuticals, Inc. (ZNTL) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 2, 2024, Lackner Mark's relationship to Zentalis Pharmaceuticals, Inc. (ZNTL) is Officer (Chief Scientific Officer), and currently has 195,728 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ZNTL insiders.
Data Source: SEC.
Lackner Mark - Insider Non-Derivative Transactions of ZNTL Common Stock
Lackner Mark - Insider Non-Derivative Transactions at ZNTL
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 3, 2024 | Sell -- (Common Stock) | 1585 | 11.54 | 195728 |
| Feb 2, 2024 | Acquisition -- (Common Stock) | 141000 | 0 | 197313 |
| Jan 3, 2024 | Acquisition -- (Common Stock) | 40000 | 0 | 56313 |